Mar 4, 2025 04:13PM

Dec 14, 2022 08:02AM

Jul 12, 2021 08:00AM

May 28, 2021 09:29AM

Apr 29, 2021 10:05AM

Apr 22, 2021 02:38PM

Apr 12, 2021 12:15PM Taysha Gene Therapies (TSHA) PT Raised to $67.50 at Chardan Capital Markets

Apr 12, 2021 11:18AM

Mar 23, 2021 09:03AM

Mar 23, 2021 08:00AM

Mar 22, 2021 04:19PM

Mar 17, 2021 05:10PM

Mar 16, 2021 11:47AM

Mar 8, 2021 06:40AM Passage Bio Inc. (PASG) PT Raised to $45 at Chardan Capital Markets

Mar 5, 2021 08:15AM

Mar 4, 2021 08:52AM

Jan 15, 2021 10:32AM

Jan 8, 2021 01:33PM

Jan 4, 2021 01:09PM

Dec 17, 2020 01:11PM

Nov 12, 2020 04:47PM Immunovant (IMVT) PT Raised to $60 at Chardan Capital Markets

Oct 19, 2020 09:41AM

Oct 5, 2020 07:00AM

Oct 1, 2020 10:55AM

Sep 30, 2020 07:05AM

Aug 25, 2020 11:01AM

Aug 13, 2020 08:31AM

Aug 4, 2020 02:36PM Regenxbio Inc. (RGNX) PT Lowered to $100 at Chardan Capital Markets, Following Drug Trial Update

Jul 15, 2020 10:05AM

Mar 10, 2020 11:44AM

Mar 3, 2020 10:31AM

Feb 10, 2020 09:55AM

Feb 6, 2020 12:10PM

Jan 31, 2020 10:52AM

Jan 30, 2020 10:44AM Buy Regenxbio (RGNX) for Breakup Story - Chardan Capital Markets

Jan 9, 2020 08:01AM

Dec 4, 2019 08:05AM

Dec 2, 2019 11:44AM

Nov 26, 2019 05:44AM

Nov 5, 2019 09:27AM

Oct 28, 2019 10:53AM

Oct 23, 2019 11:43AM Provention Bio Inc. (PRVB) PT Lowered to $18.50 at Chardan Capital Markets

Oct 15, 2019 09:30AM

Sep 27, 2019 07:00AM

Sep 23, 2019 06:31AM

Sep 3, 2019 07:58AM

Sep 3, 2019 02:44AM

Aug 16, 2019 08:04AM

Jul 22, 2019 05:13AM Chardan Capital Markets Downgrades VistaGen Therapeutics (VTGN) to Neutral

Jul 17, 2019 08:12AM

145 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All